DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Adjusted EPS | ₹60.38 | ₹68.83 | ₹111.53 | ₹74.75 | ₹51.86 |
What is the latest Earnings Per Share (EPS) of DIVIS LABORATORIES ?
Year | Earnings Per Share (EPS) |
---|---|
Mar2024 | ₹60.38 |
Mar2023 | ₹68.83 |
Mar2022 | ₹111.53 |
Mar2021 | ₹74.75 |
Mar2020 | ₹51.86 |
How is Earnings Per Share (EPS) of DIVIS LABORATORIES Trending?
Years | Earnings Per Share (EPS) | % Change | |
---|---|---|---|
Mar2024 | ₹60.38 | -12.28 | |
Mar2023 | ₹68.83 | -38.29 | |
Mar2022 | ₹111.53 | 49.20 | |
Mar2021 | ₹74.75 | 44.14 | |
Mar2020 | ₹51.86 | - |
Compare Earnings Per Share (EPS) of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹147,312.7 Cr | -5% | -1.1% | 71.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,155.0 Cr | -3.9% | 3% | 7.9% | Stock Analytics | |
CIPLA | ₹116,664.0 Cr | -4.4% | 0.2% | -1.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,678.0 Cr | -1.6% | 6.5% | 26.2% | Stock Analytics | |
MANKIND PHARMA | ₹101,358.0 Cr | 2.4% | 7.1% | 3.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,162.6 Cr | -2.4% | 2.4% | -5.4% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -5% |
-1.1% |
71.6% |
SENSEX | -2.5% |
1.9% |
4.9% |
You may also like the below Video Courses